Draupnir Bio ApS
38546880ActivePioneering oral small molecule degraders for extracellular disease proteins.
Biotechnology companydraupnir.bio
Yleiskatsaus
- 8
- Työntekijät
- Tuntematon
- Liikevaihto
- 2017
- Perustettu
Avainpäättäjät
Eva-Lotta Allan
Chair of the Board
@draupnir.bio
Peter Seeberger
Co-Founder
@draupnir.bio
Stefan Luzi
Board Member
@draupnir.bio
Ivan Burkov
Board Member
@draupnir.bio
+7 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Draupnir Bio is a Danish biotechnology company that specializes in the field of targeted protein degradation. The organization was founded as a spin-out from Aarhus University and the Max-Planck Society to pioneer new therapeutic approaches. They focus on developing oral, small molecule degraders th...
SACRA Therapeutics AB